Clinical Trials
18 trialsNCT06094426 2026-04-29
Autologous Tumor Infiltrating Lymphocyte Injection for the Treatment of Advanced Solid Tumors
Grit Biotechnology
Phase EARLY_PHASE1 Terminated
NCT07487597 2026-03-23
Functionally Enhanced ALPP-Targeted Engineered T Cells in Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1 Recruiting
NCT07327632 2026-02-04
This is a Multi-Center Study of IBI3026 in Participants With Locally Advanced, Unresectable or Metastatic Solid Tumors
Innovent Biologics Technology Limited (Shanghai R&D Center)
Phase EARLY_PHASE1 Recruiting
NCT07108140 2026-01-22
Engineered T-cell Therapy for Patients With ALPP-Positive Advanced Solid Tumors
TCRCure Biopharma Ltd.
Phase EARLY_PHASE1 Terminated
NCT06695689 2024-11-19
An Investigator-initiated Clinical Study of LM303 Injection for the Treatment of Advanced Solid Tumours
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Recruiting
NCT06613152 2024-09-25
HS-IT201 Injection in the Treatment of Advanced Solid Tumors
Qingdao Sino-Cell Biomedicine Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT06327997 2024-03-25
An Exploratory Study by Fast CAR T Cells
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1 Recruiting
NCT06248697 2024-02-08
Exploratory Study of MSLN-CAR T Cells Secreting PD1/CTLA-4 Nanoantibody for the Treatment of Advanced Solid Tumors
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1 Recruiting
NCT06249256 2024-02-08
An Exploratory Study on the Treatment of Advanced Solid Tumors by Fast CAR T Cells
Shanghai Cell Therapy Group Co.,Ltd
Phase EARLY_PHASE1 Recruiting
NCT05490264 2023-12-07
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
SmartNuclide Biopharma
Phase EARLY_PHASE1 Unknown
NCT05971576 2023-08-02
A Clinical Study on TILs for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05971589 2023-08-02
A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Not yet recruiting
NCT05941936 2023-07-12
A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors
Suzhou BlueHorse Therapeutics Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT05126927 2023-04-12
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
SmartNuclide Biopharma
Phase EARLY_PHASE1 Completed
NCT05580796 2023-04-03
KSH01-R02-101 Solid Tumors
TCRx Therapeutics Co.Ltd
Phase EARLY_PHASE1 Recruiting
NCT04841421 2021-04-12
Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors
Sinotau Pharmaceutical Group
Phase EARLY_PHASE1 Unknown
NCT03815084 2019-01-30
A Study of PD1 Combined With DC-NK Cell in the Treatment of Solid Tumors
Allife Medical Science and Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown
NCT03815630 2019-01-30
DC-CIK
Allife Medical Science and Technology Co., Ltd.
Phase EARLY_PHASE1 Unknown